pentobarbital will decrease the extent or outcome of buprenorphine, extended-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. People who transfer to buprenorphine lengthy-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to guar